Browse

AI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.

Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece…

The purchase hands Ipsen an experimental medicine in late-stage testing for a virus that often affects kidney transplant patients.